(S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide; Amikacin B Sulfate ; 6-O-(3-amino-3-deoxy-?-D-glucopyranosyl)-1-N-[(2S)-4-amino-2-hydroxybutanoyl]-4-O-(2,6-diamino-2,6-dideoxy-?-D-glucopyranosyl)-2-deoxy-D-streptamine
Amikacin EP Impurity H is a fully characterized chemical compound used as a reference standard of API Amikacin. The standard offered is compliant with regulatory guidelines. Amikacin EP Impurity H is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 48237-20-3
